Phenanthroline

Phenanthroline

SCHEMBL1420002

Cc1ccc(C)cc1.c1cnc2c(c1)ccc1cccnc12

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.76
MAPT P10636 5/20 0.76
CCR1 P32246 4/20 0.76
CCR8 P51685 4/20 0.76
TDP1 Q9NUW8 4/20 0.76
CCR5 P51681 3/20 0.76
HTT P42858 3/20 0.76
KDM4E B2RXH2 3/20 0.76
SMN1; SMN2 Q16637 3/20 0.76
MMP2 P08253 2/20 0.76
TSHR P16473 2/20 0.76
GMNN O75496 1/20 0.76
TP53 P04637 1/20 0.76
HSP90AA1 P07900 1/20 0.76
CYP3A4 P08684 1/20 0.76
CYP2D6 P10635 1/20 0.76
MMP9 P14780 1/20 0.76
ALOX15 P16050 1/20 0.76
NFKB1 P19838 1/20 0.76
MMP8 P22894 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthroline SCHEMBL29367277 0.87 CCR1 (1.00) LMNAMAPTCCR1CCR8TDP1
Phenanthroline SCHEMBL29354015 0.87 CCR1 (1.00) LMNAMAPTCCR1CCR8TDP1
Phenanthroline SCHEMBL8845760 0.87 CCR1 (1.00) LMNAMAPTCCR1CCR8TDP1
Phenanthroline SCHEMBL8312 0.87 CCR1 (1.00) LMNAMAPTCCR1CCR8TDP1
Phenanthroline SCHEMBL9343811 0.85 KDM4E (0.84) LMNAMAPTCCR1CCR8TDP1
SCHEMBL17995997 0.85 CCR1 (0.55) LMNAMAPTCCR1CCR8TDP1
Phenanthroline SCHEMBL22982126 0.85 CCR1 (0.94) LMNAMAPTCCR1CCR8TDP1
Phenanthroline SCHEMBL21300488 0.85 CCR1 (0.94) LMNAMAPTCCR1CCR8TDP1
Phenanthroline SCHEMBL21060516 0.85 CCR1 (0.94) LMNAMAPTCCR1CCR8TDP1
Phenanthroline SCHEMBL21044608 0.85 CCR1 (0.94) LMNAMAPTCCR1CCR8TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298737-B1 Indole compounds and organic light-emitting device including the same SAMSUNG DISPLAY CO LTD (KR) 2017-05-10 EP disclosed
US-8399880-B2 Heteroarylamine compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-03-19 US disclosed
US-8283057-B2 Heteroarylamine compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2012-10-09 US disclosed
EP-2298740-A1 1-H-benzo[g]indole compounds and organic lightemitting device including the same Samsung Mobile Display Co., Ltd. (KR) 2011-03-23 EP disclosed
EP-2298737-A1 Indole compounds and organic light-emitting device including the same Samsung Mobile Display Co., Ltd. (KR) 2011-03-23 EP disclosed
US-20110049494-A1 HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2011-03-03 US disclosed
US-20110049484-A1 HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110049494-A1 HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME INMT, TYR, HTT LMNA 2664/4885MAPT 776/4885CCR1 4622/4885
US-20110049484-A1 HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME INMT, TYR, HTT LMNA 2664/4885MAPT 776/4885CCR1 4622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.